Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine
Open Access
- 29 January 2015
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 40 (7) , 1804-1812
Abstract
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood–brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in the brains, but not in the livers, of smokers and 7-day nicotine treatment induces rat brain, but not hepatic, CYP2D. The role of nicotine-induced rat brain CYP2D in the central metabolic activation of peripherally administered codeine and resulting analgesia was investigated. Rats received 7-day nicotine (1 mg/kg subcutaneously) and/or a single propranolol (CYP2D mechanism-based inhibitor; 20 μg intracerebroventricularly) pretreatment, and then were tested for analgesia and drug levels following codeine (20 mg/kg intraperitoneally) or morphine (3.5 mg/kg intraperitoneally), matched for peak analgesia. Nicotine increased codeine analgesia (1.59X AUC0–30 min vs vehicle; pp0.1). Nicotine increased, while propranolol decreased, brain, but not plasma, morphine levels, and analgesia correlated with brain (p0.4), morphine levels after codeine. Pretreatments did not alter baseline or morphine analgesia. Here we show that brain CYP2D alters drug response despite the presence of substantial first-pass metabolism of codeine and further that nicotine induction of brain CYP2D increases codeine response in vivo. Thus variation in brain CYP2D activity, due to genetics or environment, may contribute to individual differences in response to centrally acting substrates. Exposure to nicotine may increase central drug metabolism, not detected peripherally, contributing to altered drug efficacy, onset time, and/or abuse liability.Keywords
This publication has 48 references indexed in Scilit:
- Rat Brain CYP2B-Enzymatic Activation of Chlorpyrifos to the Oxon Mediates Cholinergic NeurotoxicityToxicological Sciences, 2012
- Drug Metabolism within the Brain Changes Drug Response: Selective Manipulation of Brain CYP2B Alters Propofol EffectsNeuropsychopharmacology, 2010
- Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatmentNeuropharmacology, 2008
- The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and GeneticsDrug Metabolism Reviews, 2004
- Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal TractsAnnual Review of Pharmacology and Toxicology, 2003
- The antinociceptive effects of α7 nicotinic agonists in an acute pain modelNeuropharmacology, 2000
- Preproenkephalin mRNA and Methionine‐Enkephalin Content Are Increased in Mouse Striatum After Treatment with NicotineJournal of Neurochemistry, 1995
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- Progress in PsychiatryNew England Journal of Medicine, 1993
- Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid InjectionScience, 1972